title: Production and pathogenicity of hepatitis C virus core gene products.
abstract: Hepatitis C virus (HCV) is a major cause of chronic liver diseases, including steatosis, cirrhosis and hepatocellular carcinoma, and its infection is also associated with insulin resistance and type 2 diabetes mellitus. HCV, belonging to the Flaviviridae family, is a small enveloped virus whose positive-stranded RNA genome encoding a polyprotein. The HCV core protein is cleaved first at residue 191 by the host signal peptidase and further cleaved by the host signal peptide peptidase at about residue 177 to generate the mature core protein (a.a. 1-177) and the cleaved peptide (a.a. 178-191). Core protein could induce insulin resistance, steatosis and even hepatocellular carcinoma through various mechanisms. The peptide (a.a. 178-191) may play a role in the immune response. The polymorphism of this peptide is associated with the cellular lipid drop accumulation, contributing to steatosis development. In addition to the conventional open reading frame (ORF), in the +1 frame, an ORF overlaps with the core protein-coding sequence and encodes the alternative reading frame proteins (ARFP or core+1). ARFP/core+1/F protein could enhance hepatocyte growth and may regulate iron metabolism. In this review, we briefly summarized the current knowledge regarding the production of different core gene products and their roles in viral pathogenesis.
authors: Hui-Chun Li, Department of Biochemistry, Tzu Chi University, Hualien 97004, Taiwan.
authors: Hui-Chun
authors: HC
authors: Li
authors: Hui-Chun Li, Department of Biochemistry, Tzu Chi University, Hualien 97004, Taiwan.
authors: Hsin-Chieh
authors: HC
authors: Ma
authors: Hui-Chun Li, Department of Biochemistry, Tzu Chi University, Hualien 97004, Taiwan.
authors: Chee-Hing
authors: CH
authors: Yang
authors: Hui-Chun Li, Department of Biochemistry, Tzu Chi University, Hualien 97004, Taiwan.
authors: Shih-Yen
authors: SY
authors: Lo
mesh_terms: D000818:Animals; D000998:Antiviral Agents / Q000627:therapeutic use; D015195:Drug Design; D016174:Hepacivirus / Q000187:drug effects / Q000235:genetics / Q000378:metabolism* / Q000472:pathogenicity; D006526:Hepatitis C / Q000188:drug therapy / Q000821:virology*; D054884:Host-Pathogen Interactions; D006801:Humans; D008099:Liver / Q000187:drug effects / Q000378:metabolism / Q000821:virology*; D058990:Molecular Targeted Therapy; D015398:Signal Transduction; D014758:Viral Core Proteins / Q000235:genetics / Q000378:metabolism*; D037521:Virulence Factors / Q000235:genetics / Q000378:metabolism*
chemical_list: D000998:Antiviral Agents; D014758:Viral Core Proteins; D037521:Virulence Factors
keywords: Alternative reading frame/core+1 proteins; Core protein; Hepatitis C virus; Hepatocellular carcinoma; Insulin resistance; Interferon; Steatosis